In conclusion, our study suggests that sphingolipid metabolism may play a role in VEN resistance in CD14 positive monocytic phenotype AML by influencing the expression of BCL2 family genes, primarily BCL2 and BAX. Here, BAX is linked to acute myeloid leukemia.